Boehringer Ingelheim Viramune

Product Details


For the combination therapy of HIV-1 infection and (in several countries) for the prevention of mother-to-child transmission of HIV-1 in pregnant women who are not taking antiretroviral therapy at time of labour. Prolonged release tablets for once-daily dosing within combination therapy.

Get Reviews Widget

Leave a review

You may also like...